EPG
PCRX icon

Estate Planners Group’s Pacira BioSciences PCRX Stock Holding History

Estate Planners Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,310
Closed -$85.7K – 315
2025
Q4 		$85.7K Buy
+3,310
New +$78.7K 0.04% 102

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Estate Planners Group's PCRX Position: Q1 2026 in Review

Estate Planners Group sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 3,310 shares — an estimated $85.7K sold.

Estate Planners Group first reported a position in PCRX in Q4 2025 and held it in 1 quarter. The position peaked at $85.7K in Q4 2025. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Estate Planners Group reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
  • Estate Planners Group sold 3,310 Pacira BioSciences shares in Q1 2026, an estimated $85.7K.
  • Estate Planners Group first reported a position in Pacira BioSciences in Q4 2025 and held it in 1 quarter.
  • Estate Planners Group's Pacira BioSciences position peaked at $85.7K in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.